|
WO2015119170A1
|
|
Peptide having activity of inhibiting production of toxin by bacterium belonging to genus clostridium
|
|
JP2013227250A
|
|
Nrf2-ACTIVATING AGENT AND APPLICATION THEREOF
|
|
JP2010280582A
|
|
Anti-helicobacter agent
|
|
JP2009269836A
|
|
Growth inhibitor of colon cancer cells
|
|
JP2008199929A
|
|
Gene encoding bacteriocin of clostridium butyricum and protein thereof
|
|
JP2008143793A
|
|
New bisphenol derivative
|
|
JP2008050325A
|
|
Digestive tract-cleansing adjuvant containing butyric acid bacterium and/or lactobacillus
|
|
JP2006158216A
|
|
Microorganism having function of reducing indole
|
|
JP2006034166A
|
|
Method for producing degraded product of mannan
|
|
AU5301399A
|
|
Rugs comprising butyric acid-producing bacterium combined with bile acid component
|
|
JPH1142081A
|
|
Production of clostridium butyricum
|
|
JPH10310529A
|
|
Preventive and therapeutic medical composition for clostridium difficile diarrhea and pseudomembranous colitis
|
|
JPH08103226A
|
|
Production of feed for domestic animal, containing active ingredient such as butyric acid bacteria or the like
|
|
JPH07109224A
|
|
Therapeutic agent for function disorder of anterior stomach and fatty acid metabolic function disorder of ruminant domestic animal and treating method
|
|
JPH06292597A
|
|
Monoclonal antibody against clostridium butyricum
|
|
JPH06219957A
|
|
Agent for treatment of cryptostridium disease
|
|
JPH05208883A
|
|
Fertilizer production using culture mixture of butyric acid bacterium
|
|
JPH04154727A
|
|
Growth inhibitor for campylobacter in poultrys or domestic animals
|
|
JPH0236849A
|
|
Operating device for medical capsule
|
|
JPH0236848A
|
|
Medical capsule
|
